Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating the efficacy and safety of AK120 in adults with moderate to severe atopic dermatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED